Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Mergers & Acquisitions: Page 2
Illumina to divest Grail, will not further appeal FTC order
By
LabPulse.com staff writers
Illumina has said in a statement that it will not pursue further appeals, and will sell Grail “consistent with the European Commission's divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024.”
December 18, 2023
AstraZeneca to buy Icosavax in agreement worth up to $1.1B
By
LabPulse.com staff writers
AstraZeneca has agreed to buy vaccine developer Icosavax in a deal worth up to $1.1 billion.
December 13, 2023
PerkinElmer acquires Covaris
By
LabPulse.com staff writers
PerkinElmer has signed an agreement to acquire life sciences firm Covaris, which will expand its life sciences portfolio and provide entrance into the high-growth diagnostics end market.
December 8, 2023
Imaware acquires Binx Health’s consumer-testing business
By
LabPulse.com staff writers
Molecular diagnostics and consumer testing company Imaware has acquired Binx Health’s at-home consumer testing business for an undisclosed sum.
December 6, 2023
Thermo Fisher to acquire proteomics firm Olink
By
LabPulse.com staff writers
Thermo Fisher has announced plans to acquire Uppsala, Sweden-based proteomics company Olink for approximately $3.1 billion. The amount includes net cash of approximately $143 million.
October 17, 2023
European Commission orders Illumina to sell Grail
By
LabPulse.com staff writers
Illumina has been ordered by the European Commission to sell Grail following the European Union antitrust regulatory body’s determination to prohibit the $8 billion acquisition of the company.
October 12, 2023
Abcam founder urges shareholders to reject $5.7B sale to Danaher
By
Matt Limb
A founder of leading U.K. life sciences company Abcam has urged shareholders to reject a 4.5 billion pound ($5.7 billion) takeover bid by science and technology firm Danaher Corporation.
October 4, 2023
Investors acquire Novarum DX subsidiary from BBI Solutions
By
LabPulse.com staff writers
A group of investors have announced that they have finalized a deal to acquire diagnostics software company Novarum DX from U.K.-based BBI Solutions.
October 3, 2023
Agilent to sell Resolution Bioscience to Exact Sciences
By
LabPulse.com staff writers
Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.
September 12, 2023
LabGenomics USA acquires QDx Pathology
By
LabPulse.com staff writers
In a strategic move to expand its North American market, LabGenomics USA, a subsidiary of South Korea-based LabGenomics, has acquired diagnostic and molecular service provider QDx Pathology.
September 6, 2023
Danaher to acquire Abcam for $5.7B
By
LabPulse.com staff writers
Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays.
August 29, 2023
Agilent closes $550M liquid biopsy unit after failing to find path to profits
By
Nick Paul Taylor
When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.
August 18, 2023
Previous Page
Page 2 of 11
Next Page